Amicus Therapeutics Inc - FOLD - stock price prediction, stock price target, analyst ratings from 7 analysts

Amicus Therapeutics Inc has a share price target of US$ 14, revenue growth forecast of 19.1%, and profit growth estimate of 86.0% for FY25, based on top 7 analyst calls.